Cite
HARVARD Citation
Torres, V. et al. (n.d.). Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial. Nephrology dialysis transplantation. pp. 477-489. [Online].